Phibro Animal Health Corporation (NASDAQ:PAHC) Director Gerald K. Carlson sold 12,000 shares of the business’s stock in a transaction that occurred on Wednesday, February 15th. The stock was sold at an average price of $29.77, for a total transaction of $357,240.00. Following the sale, the director now owns 12,000 shares of the company’s stock, valued at approximately $357,240. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink.

Shares of Phibro Animal Health Corporation (NASDAQ:PAHC) opened at 29.75 on Friday. The company has a 50-day moving average of $28.45 and a 200 day moving average of $26.41. Phibro Animal Health Corporation has a 52-week low of $16.80 and a 52-week high of $30.85. The stock has a market cap of $1.17 billion, a P/E ratio of 19.97 and a beta of 1.34.

Phibro Animal Health Corporation (NASDAQ:PAHC) last posted its quarterly earnings results on Monday, February 6th. The company reported $0.39 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.35 by $0.04. Phibro Animal Health Corporation had a net margin of 7.90% and a return on equity of 63.70%. The firm had revenue of $192 million for the quarter, compared to analyst estimates of $194.16 million. During the same quarter last year, the firm posted $0.39 earnings per share. Phibro Animal Health Corporation’s revenue for the quarter was up .0% compared to the same quarter last year. Equities research analysts forecast that Phibro Animal Health Corporation will post $1.43 EPS for the current fiscal year.

Insider Buying and Selling by Quarter for Phibro Animal Health Corporation (NASDAQ:PAHC)

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, March 22nd. Investors of record on Wednesday, March 1st will be issued a $0.10 dividend. The ex-dividend date is Monday, February 27th. This represents a $0.40 annualized dividend and a yield of 1.34%. Phibro Animal Health Corporation’s payout ratio is 26.85%.

This piece of content was first published by Daily Political and is owned by of Daily Political. If you are viewing this piece of content on another domain, it was illegally stolen and republished in violation of international copyright and trademark legislation. The original version of this piece of content can be accessed at http://www.dailypolitical.com/2017/02/17/phibro-animal-health-corporation-pahc-director-gerald-k-carlson-sells-12000-shares.html.

A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. Nordea Investment Management AB raised its position in Phibro Animal Health Corporation by 546.6% in the second quarter. Nordea Investment Management AB now owns 32,668 shares of the company’s stock valued at $610,000 after buying an additional 27,616 shares during the last quarter. Emerald Acquisition Ltd. acquired a new position in Phibro Animal Health Corporation during the second quarter valued at approximately $404,000. JPMorgan Chase & Co. raised its position in Phibro Animal Health Corporation by 50,493.1% in the second quarter. JPMorgan Chase & Co. now owns 109,281 shares of the company’s stock valued at $2,039,000 after buying an additional 109,065 shares during the last quarter. Prudential Financial Inc. raised its position in Phibro Animal Health Corporation by 144.3% in the second quarter. Prudential Financial Inc. now owns 137,300 shares of the company’s stock valued at $2,562,000 after buying an additional 81,100 shares during the last quarter. Finally, Principal Financial Group Inc. raised its position in Phibro Animal Health Corporation by 3.8% in the second quarter. Principal Financial Group Inc. now owns 131,421 shares of the company’s stock valued at $2,452,000 after buying an additional 4,792 shares during the last quarter. Hedge funds and other institutional investors own 47.35% of the company’s stock.

PAHC has been the subject of several recent analyst reports. Gabelli downgraded shares of Phibro Animal Health Corporation from a “buy” rating to a “hold” rating in a research report on Thursday, November 10th. Zacks Investment Research upgraded shares of Phibro Animal Health Corporation from a “strong sell” rating to a “hold” rating in a research report on Wednesday, November 2nd. Piper Jaffray Companies upped their price target on shares of Phibro Animal Health Corporation from $32.00 to $34.00 and gave the company an “overweight” rating in a research report on Wednesday, February 8th. Finally, Macquarie downgraded shares of Phibro Animal Health Corporation from a “neutral” rating to an “underperform” rating and set a $21.00 price target for the company. in a research report on Friday, November 11th. Two analysts have rated the stock with a sell rating, two have given a hold rating and four have given a buy rating to the company. The company currently has a consensus rating of “Hold” and an average price target of $27.40.

About Phibro Animal Health Corporation

Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products.

5 Day Chart for NASDAQ:PAHC

Receive News & Ratings for Phibro Animal Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health Corporation and related companies with MarketBeat.com's FREE daily email newsletter.